Photo of Sundar Jagannath

Sundar Jagannath

  • SENIOR FACULTY Medicine, Hematology and Medical Oncology
Print ProfilePrint Profile

Certifications

  • Medical Oncology

  • American Board of Internal Medicine

Clinical Focus

Education

  • Residency, Internal Medicine
    Bronx-Lebanon Hospital Center

  • Residency, Internal Medicine
    Harper Hospital

  • Fellowship, Medical Oncology
    MD Anderson Cancer Center (Univ of Texas)

Biography

    Sundar Jagannath, MD, is Director of the Multiple Myeloma Program and Professor of Medicine (Hematology and Medical Oncology) at The Tisch Cancer Institute. Dr. Jagannath is a renowned expert in the research and treatment of multiple myeloma — a relatively rare cancer of the bone marrow.

     

    Prior to joining Mount Sinai, Dr. Jagannath served as chief of the multiple myeloma and transplant program at St. Vincent’s Hospital Comprehensive Cancer Center from 1998 until the hospital closed

    in April 2010. The transplant program, with stored stem cells of more than 300 patients, and the myeloma program with ongoing clinical trials, have been integrated into The Tisch Cancer Institute.

     

    Mount Sinai’s  Multiple Myeloma Program provides clinical care to a large patient population, including the transfer of more than 800 patients who had been receiving care at St. Vincent’s.

     

    Dr. Jagannath has published more than 180 peer-reviewed articles in top publications, including the New England Journal of Medicine, Blood, the Journal of Clinical Oncology and Cancer. He has presented more than 150 abstracts and authored nearly 30 book chapters.

Clinical Trials

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Jagannath during 2013 and/or 2014. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting:

  • Onyx Pharmaceuticals, Inc.

Scientific Advisory Board:

  • Celgene Corporation; Millennium Pharmaceuticals, Inc. (Takeda Pharmaceutical Company Limited )

Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose.

  • Celgene Corporation; Merck & Co., Inc.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central

Address

One Gustave L. Levy Place
Box 1185
New York, NY 10029

Tel: 212-241-7873
Ruttenberg Treatment Center

1470 Madison Avenue
New York, NY 10029

Tel: 212-241-6756
Get Directions